久久久无码人妻精品无码_6080YYY午夜理论片中无码_性无码专区_无码人妻品一区二区三区精99

Global EditionASIA 中文雙語Fran?ais
Business
Home / Business / Q and A with CEO

Serving in the name of progress

By Zhong Nan | China Daily | Updated: 2017-09-08 07:29
Share
Share - WeChat

Joaquin Duato, executive vice-president and worldwide chairman of pharmaceuticals at Johnson & Johnson. [Photo provided to China Daily]

A senior executive at Johnson & Johnson talks about the group's strategy in China and the rest of the world

Joaquin Duato had dreams of playing tennis for Spain as a child.

At 55, he is now the executive vice-president and worldwide chairman of pharmaceuticals at blue chip brand Johnson& Johnson.

"I'm an avid tennis player and as a child I used to dream of one day representing Spain," he said during a visit to Beijing.

Instead he has represented the global healthcare giant for the past 28 years and helped shape the multinational's strategy in China and across the world.

"The healthcare and pharmaceutical industries have developed notably in China during the past three decades," Duato said. "Pharmaceutical companies are getting medicines to patients faster than they were before."

Moves by the China Food and Drug Administration to streamline the approval of new medicines have opened up the industry along with updating the National Reimbursement Drug List.

Last month, the Johnson & Johnson subsidiary, Xi'an Janssen Pharmaceutical Ltd, was granted approval from the CFDA for its Imbruvica capsules, which are used to treat adult patients with chronic lymphocytic leukemia and mantle cell lymphoma.

"These factors have improved the situation in China for innovation-based pharmaceutical companies," Duato added.

With more than 125,000 staff in nearly 60 countries and regions, Johnson & Johnson sells its products, such as consumer and healthcare, pharmaceuticals and medical devices, in about 200 nations and regions.

Naturally, China has become "vitally" important to the United States-based group.

In an interview with China Daily, Duato talked about the company's vision, its strategy in China, and his love of tennis and giant pandas.

What are Johnson & Johnson's plans in China during the next five years?

China is vitally important to us globally and we remain committed to investing in China, and making a significant contribution to the country's economic growth.

Since establishing operations here in 1985, we have expanded our presence significantly and today employ more than 2,500 people in our Beijing headquarters, our state-of-the-art manufacturing site in Xi'an, and our research and development operations. These include the groundbreaking R&D center in Shanghai and the Johnson & Johnson Innovation Center.

Following an investment of $290 million, our new supply chain hub for innovation in Asia is scheduled to open in Xi'an (in Shaanxi province) in 2019. The objective is to serve the rapidly expanding needs of China and other markets in the region. The plant is expected to set a new standard in pharmaceutical manufacturing here.

At full capacity, the plant is expected to produce 400 million tablets, capsules, creams, suppositories and powders a year.

What are your priorities in the country?

Globally, and in China, our strategy is to focus on discovering and developing transformational medical innovations for patients in six high priority disease areas, which address major unmet (unfulfilled) treatment needs.

These include oncology, immunology, neuroscience, infectious diseases, cardiovascular and pulmonary hypertension.

We will (also) continue to support China's aspiration to become a leading global pharmaceutical innovator through forward-looking investments. This will enable the discovery of game-changing therapies which address unmet medical needs.

What business opportunities will emerge through the Belt and Road Initiative?

Xi'an Janssen was, and will continue to be, a forerunner in establishing joint ventures with local partners in China. We established our operations in Shaanxi province in 1985, a critical area of the Belt and Road Initiative.

We also attribute these joint-venture partnerships and our continued investment in Xi'an as critical factors to our success in China. We will continue this model (in the future).

What is your biggest achievement here?

I am proud of guiding the business toward a greater focus on transformational medical innovations for patients.

Zytiga, a new kind of treatment for men with (a type of) prostate cancer, is a great example of cutting-edge science and true medical innovation that significantly prolongs lives.

How will you compete with competitors across the world and in China?

In 2011, we made the decision to focus our business on identifying and bringing transformational medical innovation. We are an innovation-based company which globally spends 50 percent more in research and development than in sales and marketing.

With a growing core business of medicines and a strong lineup of innovative products expected to launch or file during the next five years, we are leading the industry in advancing the health of patients around the world.

With our proven global commercial capabilities, we are well-positioned to continue delivering strong, long-term, sustainable growth.

How does digital technology affect your business?

Digital technology is important in discovery and development because we use information technology to screen targets and to model our clinical trial designs.

It is critical in manufacturing as we use machine learning and artificial intelligence, or AI, to identify areas in which we can eliminate waste and establish better quality control measures.

We now have access to vast amounts of data about how our medicines are used by physicians and patients once they are on the market. So this helps us better understand the risk-benefit ratio.

What makes an effective leader of a major multinational company?

I am proud to have worked at Johnson & Johnson for more than 28 years. I have had a varied career in different sectors of the healthcare industry, and in different countries and regions around the world. This has helped me continue to evolve and adapt my leadership style.

For the first half of my career, I was based in Europe and I was successful by using a direct, straight forward leadership style. But after moving to the United States I had to re-evaluate my style and learn to navigate cultural differences.

I would say my key leadership approach is adaptability-being able to draw upon what best suits the situation and the team I am leading.

How has your style changed over time?

Different business challenges need different leadership styles. When I became the head of our North American operation, I had to work quickly and alone to guide the business through a challenging turnaround.

But once it had stabilized, I had to open up to a more inclusive and consultative leadership style as we developed a long-term strategy for growth.

How do you handle setbacks?

I view setbacks as opportunities to grow, both as an individual and as a business. The challenges and hardships our group faced during the 2007 recession can almost be seen as a necessary step in achieving the remarkable success we have today.

The setbacks we faced forced us to make our organization a leaner and more focused operation. Our extremely successful model of embracing innovation was born.

So now, whenever I am faced with a setback, I always look for an opportunity that might arise.

What are your hobbies?

My role involves a lot of travel, so whenever I am at home my first priority is spending time with my family. I love being with my wife, son and daughter.

This summer, I have spent a number of days traveling with my family to visit potential colleges that my daughter might attend next year.

I am also an avid tennis player and as a child I used to dream of one day representing Spain.

How do you spend your free time in China?

Usually, I am focused on meetings with customers and government officials. But I understand that through our collaboration with Shaanxi Rare Wild Animals Rescue and Research Center, which aims to further protect the giant panda in China, we had the honor of naming a baby panda "Johnson& Johnson". If I have free time, I am hoping to visit him.

CV

Age: 55

Nationality: Spanish and American

Career:

2017 onwards: Chairman of the Board, PhRMA

2011 onwards: Worldwide Chairman, Pharmaceuticals, Johnson& Johnson

2009-11: Company Group Chairman, Americas, The Janssen Pharmaceutical Companies of Johnson& Johnson

2007-09: Company Group Chairman, Diagnostics, Johnson & Johnson

2005-07: President, Ortho Biotech Products LP, Johnson& Johnson

Education: Undergraduate degree in Economics and Business

MBA from ESADE, Barcelona

Masters of International Management from Thunderbird, Phoenix, US.

Family: Married with a son and a daughter

Top
BACK TO THE TOP
English
Copyright 1994 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
CLOSE
 
久久久无码人妻精品无码_6080YYY午夜理论片中无码_性无码专区_无码人妻品一区二区三区精99

    拔插拔插海外华人免费| 国产第一页视频| 日本va中文字幕| 性做爰过程免费播放| 国产精品wwwww| 日韩久久久久久久久久久久| 男人插女人下面免费视频| av一区二区三区免费观看| 色哟哟精品视频| 岛国大片在线播放| 一级片免费在线观看视频| 情侣黄网站免费看| 久久亚洲国产成人精品无码区| 手机看片福利日韩| 亚洲熟妇无码一区二区三区| 吴梦梦av在线| 向日葵污视频在线观看| 九色在线视频观看| 妞干网视频在线观看| 国产精品久久久毛片| 日韩av综合在线观看| 男人天堂网站在线| 捷克做爰xxxⅹ性视频| 超碰超碰在线观看| 黄色a级片免费| 国产精品50p| 亚洲熟妇无码一区二区三区| 欧美日韩中文字幕在线播放| 福利视频999| 中文字幕视频在线免费观看| 超碰网在线观看| 国产中文字幕在线免费观看| 欧美在线观看视频免费| 中文字幕第三区| 加勒比av中文字幕| 青青草原国产在线视频| 国产视频一区二区三区在线播放| 日韩免费一级视频| 精品少妇人欧美激情在线观看| 欧洲美女和动交zoz0z| 日本福利视频导航| 日韩av影视大全| 懂色av一区二区三区四区五区| 亚洲欧美日韩三级| 午夜精品免费看| 色一情一区二区三区| 欧美第一页浮力影院| 黄色在线视频网| 国内外成人免费在线视频| 最新中文字幕2018| 最新中文字幕2018| 视频免费1区二区三区 | 欧美 国产 精品| 免费日韩在线观看| 欧美在线观看黄| av在线免费观看国产| 久草视频这里只有精品| 九九爱精品视频| 国产精品成人久久电影| 婷婷五月综合缴情在线视频| 日韩a∨精品日韩在线观看| 国产原创popny丨九色| 97国产精东麻豆人妻电影| 中国丰满人妻videoshd| 992kp快乐看片永久免费网址| 亚洲天堂2018av| 精品亚洲视频在线| eeuss中文| www.av片| 国产精品天天av精麻传媒| www.亚洲高清| 成年人免费观看的视频| 欧美交换配乱吟粗大25p| 精品无码一区二区三区在线| 成人黄色一区二区| 在线观看中文av| 日韩国产小视频| 国产av无码专区亚洲精品| 国模私拍视频在线观看| 在线观看成人免费| jizzjizz国产精品喷水| 日本888xxxx| 亚洲精品偷拍视频| 国产99久久九九精品无码| 99九九99九九九99九他书对| 日本精品久久久久久久久久| 免费午夜视频在线观看| 不卡中文字幕在线| 日韩免费一级视频| 97人人爽人人| 国产资源在线视频| 五月激情五月婷婷| 国产美女主播在线播放| 国产又粗又长又大的视频| 福利网在线观看| 日韩黄色片视频| 婷婷视频在线播放| 啊啊啊一区二区| 懂色av一区二区三区四区五区| 成人综合视频在线| 午夜啪啪免费视频| 日韩 欧美 高清| 男同互操gay射视频在线看| 欧美牲交a欧美牲交aⅴ免费真| 99精品一级欧美片免费播放| 任你操这里只有精品| 成人在线免费观看网址| 我看黄色一级片| 欧美黑人在线观看| 在线看免费毛片| 韩国日本在线视频| 青青在线视频免费观看| 美女在线视频一区二区| heyzo亚洲| 4444在线观看| 亚洲欧美手机在线| 久草综合在线观看| 成人小视频在线观看免费| 国产无遮挡猛进猛出免费软件 | 成人日韩在线视频| 免费观看日韩毛片| 青青视频免费在线| 久久久精品高清| 在线视频日韩一区| 国产二级片在线观看| 国产成人一二三区| 午夜免费一级片| 天天爽天天爽夜夜爽| 国产v片免费观看| 高清无码视频直接看| 久久久精品视频国产| mm131国产精品| 91香蕉视频导航| 大肉大捧一进一出好爽动态图| 妺妺窝人体色777777| 成人黄色片免费| 特级黄色录像片| 色网站在线视频| 尤蜜粉嫩av国产一区二区三区| 国内性生活视频| 男人添女荫道口女人有什么感觉| 91手机视频在线| 国产人妻777人伦精品hd| 欧美性猛交xxx乱久交| 国产精品久久久久久久久电影网| 日韩不卡的av| 色婷婷成人在线| 成人在线观看黄| 99精品视频在线看| 国产精品一区二区免费在线观看| 高清欧美精品xxxxx| 欧美激情亚洲天堂| 特级西西444| 在线观看成人免费| 天堂v在线视频| 久色视频在线播放| 欧美 日韩 国产精品| 久久久久亚洲av无码专区喷水| 亚洲第一成肉网| 福利视频999| 亚洲综合20p| 99re99热| 中文字幕第50页| 丰满人妻一区二区三区53号| 8x8x华人在线| 国产资源在线免费观看| 国产精品69久久久| 国内精品视频一区二区三区| 欧美视频在线观看网站| 日本精品一区二区三区四区| 逼特逼视频在线| 国产成人无码av在线播放dvd| 可以在线看的黄色网址| 一本久道综合色婷婷五月| youjizzxxxx18| 天堂在线中文在线| 自拍偷拍视频在线| 菠萝蜜视频在线观看入口| 青青草成人免费在线视频| 能在线观看的av| 中文字幕亚洲欧洲| 国产成人精品免费看在线播放| 国产小视频免费| 男人操女人免费软件| 久久精品影视大全| 日韩不卡的av| 日韩国产一级片| 91淫黄看大片| 中文字幕免费高| 可以在线看的av网站| 欧美三级理论片| 成人在线免费观看网址| 无码中文字幕色专区| 黄色在线视频网| 国产 欧美 日本| 成年人在线看片| 艳母动漫在线观看| www.爱色av.com| 99精品999| 中国丰满熟妇xxxx性|